Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Genomic determinants of hepatitis C virus antiviral therapy outcomes: toward individualized treatment.

Annals of hepatology - 1 Jan 2000

Venegas Mauricio, Brahm Javier, Villanueva Rodrigo A

Abstract excerpt

Hepatitis C virus (HCV) is an important global health problem with an estimated prevalence of more than 170 million infected individuals worldwide. Currently, the standard antiviral therapy, based on pegylated interferon alpha and ribavirin, can achieve a virological response in only nearly 50% of the patients infected with HCV genotype 1, the most widely distributed globally. During the last years, relevant data...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Drug Therapy, Combination
Share to Hepatitis C
Share to Interferons

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Interleukins

Share to Patient Selection

Share to Precision Medicine

Share to Pyrophosphatases

Share to Receptors, LDL

Source

Identifiers

PMID: 23109445

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Genomic determinants of hepatitis C virus antiviral therapy outcomes: toward individualized treatment.PMID 23109445Read ↗

Impact of host and virus genome variability on HCV replication and response to interferon.Semantic proximity Read ↗

Viral and host factors associated with outcomes of hepatitis C virus infectionSemantic proximity Read ↗

Genetics, Genomics, and Proteomics: Implications for the Diagnosis and the Treatment of Chronic Hepatitis CSemantic proximity Read ↗

Host genomics and HCV personalized medicine.Semantic proximity Read ↗

Hepatitis C virus in the new era: perspectives in epidemiology, prevention, diagnostics and predictors of response to therapy.Semantic proximity Read ↗

Individualized therapy for hepatitis C infection: focus on the interleukin-28B polymorphism in directing therapy.Semantic proximity Read ↗

Hepatitis C virus genotypes: clinical relevance and therapeutic implications.Semantic proximity Read ↗

Role of viral and host factors in interferon based therapy of hepatitis C virus infection.Semantic proximity Read ↗

Human genetics of HCV infection phenotypes in the era of direct-acting antivirals.Semantic proximity Read ↗

The role of viral and host genetics in natural history and treatment of chronic HCV infection.Semantic proximity Read ↗

Individualization of antiviral treatment regimens for chronic hepatitis C.Semantic proximity Read ↗

Impact of hepatitis C virus heterogeneity on interferon sensitivity: an overview.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.